Policies by Subject Area

Research

• 400-10: Academic, Legal and Financial Policies of Contracts and Grants

  Ensures appropriate scientific and financial management of research, training, and other extramurally funded projects.

• 400-11: Eligibility to Submit Proposals for Extramural Funds (PI Status)

  Outlines eligibility to submit proposals for extramural funds.

• 400-12: Contract and Grant Solicitation and Acceptance or Execution

  Defines the authority to solicit and accept or execute contracts or grants for instruction or research.

• 400-16: Award Acceptance and Execution of Contracts and Grants

  Defines responsibilities for the review, acceptance, and execution of contracts and grants.

• 400-19: Research Involving Human Subjects

  Mandates compliance with all federal regulations, state laws, and University of California policies governing the use of human subjects in research.

• 400-20: Research and Instruction Using Animal Subjects

  Ensures institutional compliance with all applicable federal and state laws and regulations and University policies governing the use of animals in research.

• 400-21: Housing of Animals for Research

  Mandates that all animals used for research at UCSF must be housed in designated animal care facilities in order to comply with federal regulations.

• 400-22: Clinical Trials Registration & Reporting

  Defines UCSF standards for Clinical Trial registration and results reporting on ClinicalTrials.gov per federal requirements and publication standards.

• 400-23: Patents

  Establish the rights of the various parties interested in potentially patentable inventions.

• 400-24: Integrity of Research

  Research at UCSF must be conducted in a manner appropriate to its academic goals to protect and maintain the integrity of research and of the institution.

• 400-25: OnCore Utilization and APeX Billing Review for Clinical Trials

  Requirements to track research study participants and events in OnCore and APeX; expectations for compliance with internal control standards to ensure integrity of billing procedures for clinical trials.